MapLight Therapeutics, Inc. (MPLT)
MapLight Therapeutics, Inc. (MPLT) is a Healthcare stock tracked by StreetAlpha. MPLT reports earnings on Thu, Dec 3, 2026. The average 12-month price target from 6 analysts is $28.83, with a high of $46.00 and a low of $13.00. Analyst consensus is Buy, based on the latest ratings from 6 firms (4 buy, 2 hold, 0 sell). Over the past 90 days StreetAlpha recorded 2 whale options trades in MPLT, 0% of them bullish and 100% bearish.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →Based on 6 analysts who set a price target on MPLT in the past 90 days. The average target is $28.83, with a high of $46.00 and a low of $13.00.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Aug 31 | Needham | Target lowered | Buy | $45 → $43 |
| Aug 10 | UBS | Downgrade | Hold | $52 → $13 |
| Jul 28 | Canaccord Genuity | Target lowered | Buy | $43 → $24 |
| Jul 28 | Morgan Stanley | Downgrade | Hold | $21 |
| Jul 28 | HC Wainwright & Co. | Target lowered | Buy | $45 → $26 |
Whale Options Flow
90DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether MPLT is in one of them and how their past MPLT trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered MPLT in an article yet. Here's the latest on the wider market.
For informational purposes only. Not financial advice. Options flow and dark pool data are delayed and may be incomplete.